Pharmacology in health foods:merits and demerits of food with health claims for the prevention of metabolic syndrome.
J Pharmacol Sci
; 115(4): 476-80, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21436603
The effects of synbiotic supplementation on some cardio-metabolic risk factors in overweight and obese children: a randomized triple-masked controlled trial.
Inulin oligofructose attenuates metabolic syndrome in high-carbohydrate, high-fat diet-fed rats.
Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
Letter by Kahn Regarding Article, "Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management".
Lécba obezity u metabolického syndromu.
Effects of heat-inactivated Lactobacillus gasseri TMC0356 on metabolic characteristics and immunity of rats with the metabolic syndrome.
No effect of epigallocatechin-3-gallate with weight loss on adiposity reduction, cardiometabolic risk factors and liver function in pre-menopausal obese women.
Současné pohledy na metabolický syndrom.
Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis.
[Metabolic effects of egg white enzymatic hydrolyzates: prospects of use in persons with metabolic syndrome (short review)].